European Union · CE Marking under MDR

EU CE Marking (MDR) — Complete Technical Documentation

Under the EU Medical Device Regulation (MDR), you must build and maintain Technical Documentation (TD) that shows conformity with Annex I and supports the chosen conformity assessment route. Notified Bodies review this file set against Annex II and expect clear, consistent traceability.

We assemble and author your Technical Documentation to Annex II and build a clause-by-clause GSPR matrix for Annex I, so requirements, evidence, and rationales line up cleanly.

The result is a defendable, inspection-grade Technical Documentation set—structured exactly to Annex II and cross-referenced to Annex I GSPRs—that enables fast, low-friction Notified Body review.

Full TD authoring (Annex II)

GSPR matrix (Annex I)

Traceability & cross-references

NB submission readiness

A single, inspection-grade file set that Notified Bodies can navigate quickly.

What You Will Receive

The focus is simple: DI records entered into GUDID correctly and based on the data you provide.

Complete TD (Annex II)

Complete Technical Documentation structured to Annex II: device description, design and manufacturing, verification and validation, usability, software (if applicable), sterilization, biocompatibility, and curated cross-references to clinical and risk evidence—with a consistent hyperlink structure.

GSPR Mapping (Annex I)

A clause-by-clause GSPR matrix for Annex I: applicability per requirement, evidence/reference, concise rationale, and justified non-applicable (NA) decisions, giving Notified Bodies direct line-of-sight from requirement to proof.

Submission-readiness brief

A short submission-readiness brief that checks structure and traceability and outlines next steps for your chosen conformity assessment route under MDR (Annex IX, X, or XI).

Scope: Consulting and documentation only. We do not perform laboratory testing, do not design label artwork, and do not act as a Notified Body. Annex III/PMS activities are not included in this package.

Get Your DI Records Properly Registered in GUDID

FDA’s Global UDI Database (GUDID) holds key device identification data for your products. As the labeler, you must register Device Identifier (DI) records that match what is on your labels and packaging. Those records are visible in AccessGUDID, so missing or incorrect data shows up publicly.

Label & IFU Confirmation

Change & Revalidation Plan

Vigilance & Field Actions Routing

How we work

We keep the process straightforward: prepare the data, enter it in GUDID, and hand back a clear overview.

A healthcare professional's office. A laptop displays test results.
01

Collect

We confirm intended purpose and claims, classification rationale, and collect your existing evidence set: test reports, clinical evaluation (CER/CEP), risk management file, usability, software, sterilization, and applied standards, plus any Notified Body feedback.
02

Author & compile

We assemble and author the Technical Documentation according to Annex II: consistent structure, clear descriptions, and curated references that pull your existing evidence into a single, coherent TD set.
03

Map & cross-reference

We build the Annex I GSPR matrix (applicability → evidence → rationale), justify NA decisions, and cross-link the matrix to your TD sections and documents so reviewers can trace requirements quickly.
04

Readiness & handover

We run basic structure and traceability checks, prepare the submission-readiness brief for your Annex IX/X/XI route, and hand over an inspection-grade file set ready for Notified Body review.
05

Label/IFU confirmation

Verify correct BRH identification on labels and IFUs, and manage electronic IFU uploads where applicable.
06

Maintenance & vigilance

Operate the change and revalidation plan, and route vigilance/field-action communications so ANVISA timelines and obligations are met.

What We Need From You

We rely on you as the labeler for UDI choices and product facts; we handle the data entry.

Consulting and documentation only. We do not perform laboratory testing, do not design label artwork, do not deliver Annex III/PMS activities in this package, and do not act as a Notified Body. Your organisation remains responsible for testing, labelling, PMS, and all formal submissions to Notified Bodies and authorities.

Scope & Exclusions

We keep the service precisely defined so your internal team, Sobel, and your partners in Brazil understand who does what—and where additional services might be needed.

In Scope

Out of Scope

Inputs We Need From Your Team

Consulting and documentation support only. We do not design UDI schemes, do not create Annex VI data, do not select issuing agencies, and do not act as a notified body, importer, or label designer. You remain responsible for UDI assignment, Annex VI content, technical documentation, and all formal submissions in EUDAMED.

When You Need a Brazilian Registration Holder

Typical situations where appointing a BRH becomes essential for Brazil market access:

FREQUENTLY ASKED QUESTIONS

Yes. We assemble Technical Documentation according to Annex II and build an Annex I GSPR matrix. Together, these address the core content and traceability expectations for MDR conformity assessment.

No. We provide consulting and documentation only. You remain responsible for laboratory testing, label artwork, and all interactions with your Notified Body.

We structure the Technical Documentation and GSPR matrix so they fit your chosen route under MDR—typically Annex IX (QMS with assessment), Annex X (type examination), or Annex XI (production quality assurance).

Yes. We start from what you already have, identify gaps and inconsistencies, and then author and assemble a complete, traceable TD set with an aligned GSPR matrix.

Short Glossary

A woman holding a smartphone in one hand and a stethoscope in the other. She wears medical gloves and appears to be in a hospital setting. Regulatory Medical Device Consultancy.

Build my Technical Documentation

We’ll reply with a proposed slot and a short intake checklist.

Contact Us

We would love to speak with you.
Feel free to reach out using the below details.

Newsletter

Subscribe to our newsletter to receive the latest updates and insights.

You may unsubscribe at any time using the link in our newsletter.